爱尔眼科：公司的欧洲子公司经验丰富，老花手术业务发展良好

Group 1 - The core viewpoint of the article highlights the low awareness and acceptance of presbyopia treatment among the elderly in China, contrasting with higher acceptance in Europe [2] - The company, Aier Eye Hospital (300015.SZ), acknowledges that the treatment of presbyopia is still in its early stages in China, with a very low prevalence rate [2] - Aier Eye Hospital is actively developing services for age-related eye diseases and presbyopia treatment, leveraging the experience of its European subsidiary [2] Group 2 - The company has opened presbyopia clinics in multiple locations and plans to establish a presbyopia study group to provide suitable visual solutions for the elderly [2] - There is an expectation for continued growth in presbyopia treatment as the purchasing power of the target demographic increases and their demand for visual quality rises [2]